Characteristics | Chronic HBV patients (n = 1007) | Controls (n = 1040) | P-value |
---|---|---|---|
Age, years | 48.19 ± 11.3 | 49.31 ± 10.57 | 0.058 |
Male/female, % | 65.9/34.1 | 61.6/38.4 | 0.024 |
Smoking, n (%) | 224 (22.3%) | 198 (19.3%) | 0.080 |
Drinking, n (%) | 291 (28.9%) | 265 (25.5%) | 0.091 |
Hypertension*, n (%) | 166 (16.5%) | 147 (14.1%) | 0.140 |
Fatty liver, n (%) | 194 (19.3%) | 225 (21.6%) | 0.184 |
BMI, kg/m2 | 24.11 (22.49, 26.70) | 25.04 (22.20, 27.91) | 0.118 |
HOMA-IR | 2.33 (1.96, 2.66) | 2.36 (1.96, 2.68) | 0.766 |
ALT, IU/L | 59.66 (32.97, 87.08) | 27.19 (19.67, 39.39) |  < 0.001 |
AST, IU/L | 57.60 (33.00, 86.90) | 26.73 (22.03, 34.82) |  < 0.001 |
ALB, g/L | 31.70 (28.70, 35.30) | 37.05 (31.02, 41.81) |  < 0.001 |
Cholinesterase, IU/L | 9080 (7620, 10,460) | 10,904 (9001, 13,406) |  < 0.001 |
PLT (109/L) | 101 (81, 122) | 186 (117.25, 250) |  < 0.001 |
HBeAg positive, % | 827 (82.1%) | Â | Â |
HBsAg (log10IU/ml)) | 3.75 (3.55, 3.89) | Â | Â |
HBV DNA (log10IU/ml) | 6.3 (5.14, 7.7) | Â | Â |
HBV genotype 2/3, % | 20.5/79.5 | Â | Â |
E, kPa | Â | Â | Â |
  F0–2 | 7.6 (6.75, 8.4) |  |  |
  F3–4 | 11.3 (10.1, 12.6) |  |  |